InvestorsHub Logo
Followers 22
Posts 3749
Boards Moderated 0
Alias Born 05/15/2014

Re: jackson73 post# 141036

Tuesday, 06/09/2020 9:01:03 AM

Tuesday, June 09, 2020 9:01:03 AM

Post# of 182998
ONCS - OncoSec Expands KEYNOTE-890 Trial into First-Line Metastatic Triple Negative Breast Cancer (mTNBC) with TAVO and KEYTRUDA Plus Chemotherapy
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.